DM - Small molecule digital twin platform
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- tbd@fda.gov
- Christopher Scott christopher.scott@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is forecasting a new requirement for a small molecule digital twin platform, focusing on domestic manufacturing equipment installation and integration of Siemens hardware/software. The project specifically involves a mixer for signal exchange with third-party equipment (Glatt), with an estimated solicitation release date of November 1, 2025, and a projected award date of January 1, 2026. The contract falls under the Analytical Laboratory Instrument Manufacturing NAICS code 334516, indicating a specialized technical procurement.
While specific award values are not detailed, the opportunity is designated without a set-aside, suggesting open competition for potential contractors. Key points of contact include Christopher Scott (christopher.scott@fda.hhs.gov) from the FDA, who may provide additional details about the procurement. The project appears to be centered within the FDA's organizational framework, likely involving advanced digital twin technology for pharmaceutical or scientific research applications, with implementation expected to commence in early 2026.
Forecast text
Domestic Manufacturing Equipment Complete installation and integration of Siemens HW/SW to support small molecule digital twin projects DM - Mixer for Signal Exchange to Third Party Equipment (Glatt)
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast